Resources
About Us
The global Molecular cytogenetics market will grow at a CAGR of 11% from 2017 to 2022 to reach USD 2,266.4 million by 2022, according to this latest publication from Meticulous Research®. The molecular cytogenetics market is driven by increasing focus on preventive healthcare measures, growing genetic abnormalities, increasing aging population and subsequent rise in various chronic diseases, growing need to reduce mounting healthcare cost, and increasing focus on clinical and research diagnosis. Moreover, increasing focus on targeted based therapies and growing predictive and presymptomatic genetic testing further provides significant opportunities in this market. However, lack of awareness about diagnostic technologies, the high cost of diagnosis, and unfavorable reimbursement scenario within the molecular cytogenetics, and technical limitations and complexities of the equipment have embraced the growth of molecular cytogenetic market globally. While the transition from fluorescence in situ hybridization to array based techniques is one of the notable trends observed in the global molecular cytogenetics market.
Market Segmentation
The global molecular cytogenetics market is mainly segmented by technique (fluorescence in situ hybridization, comparative genomic hybridization, in situ hybridization, karyotyping, and banding techniques), by product (instruments, kits and reagents, software, services, and consumable/accessories ), by application (oncology, genetic disorders, personalized medicines, and other), and by end user (pharmaceuticals and biotechnological companies, clinical and diagnostic laboratories, and academic institutes). The comparative genome hybridization is further classified into an array based CGH and matrix based CGH, whereas, the karyotyping market is further segmented into Spectral Karyotyping and virtual karyotyping. Banding techniques are further classified into G banding, R banding, C banding, Q banding, and T banding.
Browse in-depth Report on :https://www.meticulousresearch.com/product/molecular-cytogenetics-market-3067
The comparative genomic hybridization technology segment commanded the largest share of the global molecular cytogenetics market and is expected to grow at the fastest CAGR in the next five years mainly due to the growing adoption of array CGH for various applications.
Geographic Overview
Geographically, the global molecular cytogenetics market is segmented into five major regions, namely North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. These regions are further analyzed at a country level with the detailed qualitative and quantitative analysis. North America accounted for the major share in the global molecular cytogenetics market in 2016, followed by Europe, and Asia-Pacific region. The large share of this region is primarily attributed to the increased funding for medical research, stringent drug development regulations which demand molecular cytogenetics techniques, growing aging population and thereby prevalence of various chronic diseases, and direct & indirect financial investments in the pharma biotech companies. However, Asia-Pacific region possesses lucrative growth potential for the molecular cytogenetic market during the forecast period owing to the increasing demand in China and India, growing population, various technological advancements, growing investment from government & non-government bodies, and growing pharma biotech industry in the region.
Key Players
The leading companies have employed various strategies to expand their product and application offerings, global footprint, and augment their market share. The key strategies followed by most companies in the global molecular cytogenetics market were new product developments, acquisitions, and expansions. The key players in the global molecular cytogenetics market are Thermo Fisher Scientific, Abbott Laboratories, Agilent Technologies, PerkinElmer, Bio-Rad Laboratories, Applied Spectral Imaging, Quest Diagnostics, Roche Diagnostics, Danaher Corporation, Illumina, and Oxford Gene Technology.
Key questions answered in the report-
About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicated market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Meticulous Research® produces global reports and custom studies for North America, Europe, Latin America, Asia-Pacific, and the Middle East and Africa regions. These reports are used by our clients for marketing and strategic planning in various sectors.
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Connect with us on Twitter- https://twitter.com/MeticulousR123
Kenya IVD Market to be Worth $68.66 Billion by 2032
Read More
Cardiac Biomarkers Market to be Worth $10.08 Billion by 2031
Read More
Cytogenetics Market to be Worth $5.5 Billion by 2031
Read More
Metagenomics Market to be Worth $ 6.71 Billion by 2031
Read More
Dental Lasers Market to be Worth $618.7 million by 2032
Read More
Bakuchiol Serum Market to Reach $4.41 Million by 2032
Read More
Burn Care Market to be Worth $4.32 Billion by 2032
Read More
Africa Medical Devices Market to be Worth $7.14 Billion by 2032
Read More
Middle East Medical Devices Market to be Worth $8.8 Billion by 2032
Read More
Surgical Drills Market to be Worth $1.71 Billion by 2032
Read More
Tissue Engineering Market to reach $7.41 Billion by 2032
Read More
Dental Prosthetics Market to be Worth $ 19.6 Billion by 2032
Read More
Whole Genome Sequencing Market to be Worth $7.17 Billion by 2031
Read More
IVD Assay Development Market to be Worth $8.39 Billion by 2031
Read More
Neurogenomics Market to Reach $4.68 Billion by 2031
Read More
India VNA & PACS Market to Reach $341.6 Million by 2031
Read More
China Microarray Market to Be Worth $910.4 Million by 2031
Read More
China Neurogenomics Market to Reach $562.1 Million by 2031
Read More
ELISA Market to be Worth $32.69 Billion by 2032
Read More
DNA Sequencing Market to be Worth $21.30 Billion by 2031
Read More
Oral Care Market to be Worth $70 Billion by 2032
Read More
Spirometer Market to be Worth $1.80 Billion by 2032
Read More
Viral Vaccines Market to be Worth $64.18 Billion by 2031
Read More
Pet Care Market to be Worth $287.96 Billion by 2032
Read More
Regenerative Medicine Market to be Worth $37.27 Billion by 2031
Read More
Hemostats Market to be Worth $5.32 Billion by 2032
Read More
Bioreactors Market to be Worth $39.96 Billion by 2032
Read More
Protein Assays Market to be Worth $4.36 Billion by 2032
Read More
Veterinary API Market to Reach $15.84 Billion by 2031
Read More
Asia-Pacific NGS Automation Market to be Worth $371 Million by 2032
Read More
Latin America NGS Market to be Worth $765.2 Million by 2032
Read More
Biochemical Reagents Market to be Worth $39.61 Billion by 2032
Read More
Microarray Kits Market to be Worth $2.51 Billion by 2032
Read More
Antibody Production Market to Reach $58.35 Billion by 2032
Read More
Middle East IVD Market to be Worth $2.15 Billion by 2032
Read More
Spatial Genomics Market to be Worth $3.23 Billion by 2031
Read More
Asia-Pacific IVD Market to be Worth $36.02 Billion by 2032
Read More
Europe NGS Market to be Worth $6.40 Billion by 2032
Read More
Lab Automation Market to be Worth $11.31 Billion by 2031
Read More
Bioinformatics Market to Reach $31.71 Billion by 2031
Read More
Europe IVD Market to be Worth $39.77 Billion by 2032
Read More
Sequencing Kits Market to be Worth $25.29 Billion by 2031
Read More
Veterinary API Market to Reach $15.84 Billion by 2032
Read More
U.S. Ambulatory EHR Market to be Worth $3.97 Billion by 2031
Read More
Sample Preparation Market to be Worth $12.77 Billion by 2031
Read More
Surgical Robots Market Worth $25.47 Billion by 2032
Read More
Medical Coatings Market Worth $3.32 Billion by 2032
Read More
Digital Therapeutics Market to be Worth $56.34 Billion by 2031
Read More
Liquid Handling Systems Market Worth $6.99 Billion by 2029
Read More
Electrosurgery Market to be Worth $8.99 Billion by 2031
Read More
Radiation Dose Management Market Worth $749.1 Million by 2029
Read More
Molecular Diagnostics Market Worth $46.69 Billion by 2030
Read More
Newborn Screening Market to be Worth $2.69 Billion by 2031
Read More
Pharmacogenomics Market to be Worth $19.5 Billion by 2031
Read More
Dental Practice Management Software Market Worth $ 3.11 Billion by 2029
Read More
Nepal IVD Market Worth $62.7 Million by 2029
Read More
Pharmaceutical Contract Packaging Market Worth $42.03 Billion by 2029
Read More
Indonesia IVD Market Worth $1.11 Billion by 2029
Read More
Medical Waste Management Market Worth $17.02 billion by 2030
Read More
Empty Capsules Market Worth $4.47 Billion by 2029
Read More
Clear Aligners Market to be worth $18.8 Billion by 2030
Read More
HLA Typing Market Worth $1.9 Billion by 2029
Read More
Real-world Data Market Worth $1.66 billion by 2029
Read More
Track and Trace Solutions Market Worth $27.27 billion by 2029
Read More
Surface Disinfectant Market Worth $9.52 Billion by 2029
Read More
Electronic Lab Notebook Market Worth $787.7 million by 2029
Read More
Rapid Diagnostics Market to be Worth $22.65 Billion By 2031
Read More
Plasma Therapy Market Worth $882.5 Million by 2028
Read More
Peripheral Vascular Devices Market Worth $12.02 Billion by 2028
Read More
Biomaterials Market to Reach 128.7 Billion USD by 2023
Read More
Vaccine Storage Equipment Market Worth $1.83 billion by 2027
Read More
Plasma Fractionation Market Worth $46.9 Billion by 2029
Read More
Home Healthcare Market to be Worth $514.5 Billion by 2030
Read More
Cardiac Pacemaker Devices Market Worth $4.34 Billion by 2028
Read More
European Laboratory Informatics Market Worth $1,084.3 Million By 2024
Read More
Competent Cells Market Worth 2,318.6 Million USD By 2023
Read More
Cancer Immunotherapy Market to be Worth $267.2 Billion by 2030
Read More
Multimodal Imaging Market Worth $1.6 Billion By 2024
Read More
Pulse Lavage Market to be Worth $661.1 Million by 2030
Read More
Medical Cooling Systems Market Worth $2.8 Billion By 2024
Read More
Tissue Diagnostics Market Worth $8.52 Billion by 2029
Read More
Endoscopy Equipment Market Worth $59.8 Billion by 2029
Read More
African Forensic DNA Testing Market Worth $136.3 Million by 2025
Read More
Clinical Trial Supplies Market to be Worth $5.59 Billion by 2031
Read More
Infection Control Market Worth $58.2 Billion by 2027
Read More
Sleep Apnea Devices Market Worth $12.9 billion by 2027
Read More
Medical 3D Printing Market To Reach $983.2 Million By 2020
Read More
Genomics Market to be Worth $70.52 Billion by 2031
Read More
Analytical Standards Market Worth $2.66 Billion By 2027
Read More
Sterilization Equipment Market to be Worth $34.2 Billion by 2035
Read More
Telehealth Market Worth $539.73 Billion by 2029
Read More
Cell Culture Market Worth $48.63 Billion by 2029
Read More
Antimicrobial Coatings Market to be Worth $12.41 Billion by 2031
Read More
Flow Cytometry Market Worth $6.4 Billion by 2027
Read More
Medical Aesthetics Market Worth $29.43 billion by 2029
Read More
Oligonucleotide Synthesis Market Worth $3.9 Billion by 2025
Read More
In Vitro Diagnostics Market to be Worth $116.28 Billion by 2031
Read More
Dental Implants Market Worth $6.52 Billion by 2029
Read More
Active Implantable Devices Market Worth 24.02 Billion USD By 2022
Read More
Ventilators Market to be Worth $13.23 Billion by 2031
Read More
Dialysis Market to be Worth $36.6 Billion by 2031
Read More
Task Trainers Market to Be Worth $2.9 Billion by 2032
Read More
Plasmapheresis Market to be Worth $2.55 Billion by 2030
Read More
Diabetes Care Devices Market Worth $31.9 Billion by 2028
Read More
Clinical Genomics Market Worth 879.0 Million USD By 2023
Read More
IVD Quality Control Market to be Worth $2.28 Billion by 2031
Read More
Laboratory Informatics Market Worth $6.1 Billion by 2030
Read More
Chromatography Data Systems Market to be Worth $1.7 billion by 2030
Read More
Bone Growth Stimulators Market Worth $1.94 Billion by 2030
Read More
Digital Diabetes Market worth $12.03 billion by 2025
Read More
Trocars Market Worth $968.5 Million by 2024
Read More
Healthcare Virtual Assistant Market Worth $1.76 Billion By 2025
Read More
Europe Hospital Beds Market to be Worth $2.09 Billion by 2030
Read More
Immunoassay Market Worth $46.49 Billion by 2028
Read More
Hospital Beds Market to Reach $7.09 Billion by 2031
Read More
Urinalysis Market Worth $2.19 billion by 2027
Read More
Medical Image Management Market Worth $7.22 billion by 2030
Read More
Breast Imaging Market Worth $7.08 Billion by 2027
Read More
VNA & PACS Market to be Worth $6.50 Billion by 2031
Read More